Allergan's most recent trend suggests a bullish bias. One trading opportunity on Allergan is a Bull Put Spread using a strike $210.00 short put and a strike $200.00 long put offers a potential 12.36% return on risk over the next 29 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $210.00 by expiration. The full premium credit of $1.10 would be kept by the premium seller. The risk of $8.90 would be incurred if the stock dropped below the $200.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Allergan is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Allergan is bullish.
The RSI indicator is at 54.7 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Allergan
Spain's Almirall gains on report of Actavis interest
Fri, 19 Dec 2014 17:29:16 GMT
Reuters – UK Focus – Shares in Spanish drugmaker Almirall jumped 9 percent on Friday after a Bloomberg report of potential takeover interest from Actavis. Almirall played down the report, saying in a regulatory filing that …
Ackman Accused of Insider Trading in Allergan Shareholder Suit
Fri, 19 Dec 2014 00:10:42 GMT
AGN SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Involving Allergan, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 16, 2015 — AGN
Thu, 18 Dec 2014 22:48:19 GMT
GlobeNewswire – NEW YORK — Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who sold Allergan, …
Lawsuit accuses Ackman, Valeant of insider trading in Allergan stock
Thu, 18 Dec 2014 21:34:00 GMT
EQUITY ALERT: The Rosen Law Firm Announces the Filing of Securities Class Action on Behalf of Sellers of Allergan Inc. Stock From February 25, 2014 to April 21, 2014 Seeking to Recover Losses — AGN
Thu, 18 Dec 2014 20:59:05 GMT
GlobeNewswire – NEW YORK — The Rosen Law Firm, a global investor rights firm, announced today that a class action lawsuit has been filed on behalf of all sellers of Allergan Inc. stock between February 25, 2014 and April …
Related Posts
Also on Market Tamer…
Follow Us on Facebook